MacLeod Daniel T, Choi Nancy M, Briney Bryan, Garces Fernando, Ver Lorena S, Landais Elise, Murrell Ben, Wrin Terri, Kilembe William, Liang Chi-Hui, Ramos Alejandra, Bian Chaoran B, Wickramasinghe Lalinda, Kong Leopold, Eren Kemal, Wu Chung-Yi, Wong Chi-Huey, Kosakovsky Pond Sergei L, Wilson Ian A, Burton Dennis R, Poignard Pascal
International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; International AIDS Vaccine Initiative, New York, NY 10038, USA.
International AIDS Vaccine Initiative Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA 92037, USA; Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA; Scripps Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery, The Scripps Research Institute, La Jolla, CA 92037, USA.
Immunity. 2016 May 17;44(5):1215-26. doi: 10.1016/j.immuni.2016.04.016.
The high-mannose patch on HIV Env is a preferred target for broadly neutralizing antibodies (bnAbs), but to date, no vaccination regimen has elicited bnAbs against this region. Here, we present the development of a bnAb lineage targeting the high-mannose patch in an HIV-1 subtype-C-infected donor from sub-Saharan Africa. The Abs first acquired autologous neutralization, then gradually matured to achieve breadth. One Ab neutralized >47% of HIV-1 strains with only ∼11% somatic hypermutation and no insertions or deletions. By sequencing autologous env, we determined key residues that triggered the lineage and participated in Ab-Env coevolution. Next-generation sequencing of the Ab repertoire showed an early expansive diversification of the lineage followed by independent maturation of individual limbs, several of them developing notable breadth and potency. Overall, the findings are encouraging from a vaccine standpoint and suggest immunization strategies mimicking the evolution of the entire high-mannose patch and promoting maturation of multiple diverse Ab pathways.
HIV包膜上的高甘露糖区域是广泛中和抗体(bnAbs)的首选靶点,但迄今为止,尚无疫苗接种方案能诱导出针对该区域的bnAbs。在此,我们展示了在一名来自撒哈拉以南非洲的感染HIV-1 C亚型的供体中,针对高甘露糖区域的bnAb谱系的发展情况。这些抗体首先获得自体中和能力,然后逐渐成熟以实现广度。一种抗体仅通过约11%的体细胞超突变且无插入或缺失,就能中和>47%的HIV-1毒株。通过对自体env进行测序,我们确定了触发该谱系并参与抗体-包膜共同进化的关键残基。抗体库的二代测序显示,该谱系早期出现广泛的多样化,随后各个分支独立成熟,其中几个分支发展出显著的广度和效力。总体而言,从疫苗角度来看,这些发现令人鼓舞,并提示了模仿整个高甘露糖区域的进化并促进多种不同抗体途径成熟的免疫策略。